Merrimack Pharma shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Merrimack Pharma
Tip: Access up to 7 years of quarterly data
All positions including Merrimack Pharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Merrimack Pharma by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $472k | 35k | 13.41 |
| 2023-09-30 | $431k | 35k | 12.33 |
| 2023-06-30 | $174k | 14k | 12.30 |
| 2023-03-31 | $429k | 35k | 12.29 |
| 2022-12-31 | $162k | 14k | 11.46 |
| 2022-06-30 | $84k | 14k | 5.94 |
| 2019-03-31 | $184k | 26k | 6.97 |
| 2018-12-31 | $102k | 27k | 3.85 |
| 2018-09-30 | $387k | 73k | 5.32 |
| 2018-06-30 | $669k | 136k | 4.91 |
| 2018-03-31 | $232k | 29k | 8.04 |
| 2017-12-31 | $396k | 39k | 10.24 |
| 2017-09-30 | $1.6M | 109k | 14.54 |